为超敏捷环境调整敏捷开发实践:从 COVID-19 应急响应研究项目中汲取的经验教训。

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS
ACS Applied Bio Materials Pub Date : 2022-01-01 Epub Date: 2022-07-30 DOI:10.1007/s10799-022-00370-y
Salman Nazir, Brad Price, Nanda C Surendra, Katherine Kopp
{"title":"为超敏捷环境调整敏捷开发实践:从 COVID-19 应急响应研究项目中汲取的经验教训。","authors":"Salman Nazir, Brad Price, Nanda C Surendra, Katherine Kopp","doi":"10.1007/s10799-022-00370-y","DOIUrl":null,"url":null,"abstract":"<p><p>Agile development is known for efficient software development practices that enable teams to quickly develop software to cope with changing requirements. Although there is evidence that agile practices are helpful in such environments, the literature does not inform us as to whether agile practices can also be beneficial in hyper-agile environments. Such environments are characterized by an extremely fast pace of change with fluid requirements. COVID-19 vaccine distribution is one such problem that governments have had to deal with. To solve this problem, governments need to come up with robust responses by formulating teams that have the capability to provide software solutions enabling information visibility into the vaccine distribution process. Such emergent teams need to quickly understand the distribution process, oftentimes define the process itself because it might be non-existent, and build software systems to solve the problem in a matter of days. Not much is known about how systems can be developed at such a fast pace. We adopt a clinical research methodology and employ agile software development practices to develop such a mission-critical system. In the process of building the system, we learn important lessons that can be used to adapt and extend agile methodologies to be used in hyper-agile development environments. We offer these lessons as important first steps to understanding the best practices needed to develop software systems that have the capability to provide visibility into the unprecedented health challenge of distribution of life-saving COVID-19 vaccine.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362493/pdf/","citationCount":"0","resultStr":"{\"title\":\"Adapting agile development practices for hyper-agile environments: lessons learned from a COVID-19 emergency response research project.\",\"authors\":\"Salman Nazir, Brad Price, Nanda C Surendra, Katherine Kopp\",\"doi\":\"10.1007/s10799-022-00370-y\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Agile development is known for efficient software development practices that enable teams to quickly develop software to cope with changing requirements. Although there is evidence that agile practices are helpful in such environments, the literature does not inform us as to whether agile practices can also be beneficial in hyper-agile environments. Such environments are characterized by an extremely fast pace of change with fluid requirements. COVID-19 vaccine distribution is one such problem that governments have had to deal with. To solve this problem, governments need to come up with robust responses by formulating teams that have the capability to provide software solutions enabling information visibility into the vaccine distribution process. Such emergent teams need to quickly understand the distribution process, oftentimes define the process itself because it might be non-existent, and build software systems to solve the problem in a matter of days. Not much is known about how systems can be developed at such a fast pace. We adopt a clinical research methodology and employ agile software development practices to develop such a mission-critical system. In the process of building the system, we learn important lessons that can be used to adapt and extend agile methodologies to be used in hyper-agile development environments. We offer these lessons as important first steps to understanding the best practices needed to develop software systems that have the capability to provide visibility into the unprecedented health challenge of distribution of life-saving COVID-19 vaccine.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362493/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"91\",\"ListUrlMain\":\"https://doi.org/10.1007/s10799-022-00370-y\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2022/7/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"91","ListUrlMain":"https://doi.org/10.1007/s10799-022-00370-y","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/7/30 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

摘要

敏捷开发以高效的软件开发实践而著称,这些实践使团队能够快速开发软件,以应对不断变化的需求。尽管有证据表明敏捷实践在此类环境中很有帮助,但文献并没有告诉我们敏捷实践在超敏捷环境中是否也有益处。这种环境的特点是变化速度极快,需求不稳定。COVID-19 疫苗分发就是政府不得不面对的一个问题。为解决这一问题,政府需要制定强有力的应对措施,组建有能力提供软件解决方案的团队,以实现疫苗分发过程的信息可见性。这些新兴团队需要快速了解疫苗分发流程,有时还需要对流程本身进行定义,因为它可能并不存在,并在短短几天内建立软件系统来解决问题。对于如何以如此快的速度开发系统,人们知之甚少。我们采用临床研究方法和敏捷软件开发实践来开发这样一个关键任务系统。在构建系统的过程中,我们吸取了重要的经验教训,这些经验教训可用于调整和扩展敏捷方法,使其适用于超敏捷开发环境。我们将这些经验作为重要的第一步,以了解开发软件系统所需的最佳实践,这些软件系统有能力为分配拯救生命的 COVID-19 疫苗这一前所未有的健康挑战提供可视性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Adapting agile development practices for hyper-agile environments: lessons learned from a COVID-19 emergency response research project.

Adapting agile development practices for hyper-agile environments: lessons learned from a COVID-19 emergency response research project.

Adapting agile development practices for hyper-agile environments: lessons learned from a COVID-19 emergency response research project.

Adapting agile development practices for hyper-agile environments: lessons learned from a COVID-19 emergency response research project.

Agile development is known for efficient software development practices that enable teams to quickly develop software to cope with changing requirements. Although there is evidence that agile practices are helpful in such environments, the literature does not inform us as to whether agile practices can also be beneficial in hyper-agile environments. Such environments are characterized by an extremely fast pace of change with fluid requirements. COVID-19 vaccine distribution is one such problem that governments have had to deal with. To solve this problem, governments need to come up with robust responses by formulating teams that have the capability to provide software solutions enabling information visibility into the vaccine distribution process. Such emergent teams need to quickly understand the distribution process, oftentimes define the process itself because it might be non-existent, and build software systems to solve the problem in a matter of days. Not much is known about how systems can be developed at such a fast pace. We adopt a clinical research methodology and employ agile software development practices to develop such a mission-critical system. In the process of building the system, we learn important lessons that can be used to adapt and extend agile methodologies to be used in hyper-agile development environments. We offer these lessons as important first steps to understanding the best practices needed to develop software systems that have the capability to provide visibility into the unprecedented health challenge of distribution of life-saving COVID-19 vaccine.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信